Table 1.
Feature | N (%) | |
---|---|---|
Sex | Female | 1 (3.1) |
Male | 31 (96.9) | |
Tumor site | Larynx | 9 (28.1) |
Larynx (glottic and supraglottic) | 1 (3.1) | |
Larynx (glottic) | 10 (31.2) | |
Larynx (glottic and subglottic) | 1 (3.1) | |
Larynx (supraglottic) | 7 (21.9) | |
Oropharynx | 2 (6.2) | |
Epiglottis | 1 (3.1) | |
Oral cavity | 1 (3.1) | |
Age (years) | Average (SD) | 61.1 (10.7) |
Median (min–max) | 58.5 (40–83) | |
Smokea | No | – |
Yes | 27 (100) | |
Alcoholb | No | – |
Yes | 26 (100) | |
Tumor sizec | T1 | 6 (18.8) |
T2 | 7 (21.8) | |
T3 | 5 (15.6) | |
T4 | 13 (40.6) | |
Lynph node invasionc | N0 | 23 (71.9) |
N1 | 1 (3.1) | |
N2 | 1 (3.1) | |
N2a | 1 (3.1) | |
N2b | 3 (9.4) | |
N2c | 2 (6.3) | |
Inflammatory infiltrate | Peritumoral | 32 (100) |
Intratumoral | 2 (6.3) | |
Perineural invasion | No | 27 (84.4) |
Yes | 5 (15.6) | |
Differentiation grade | I | 4 (12.5) |
II | 14 (43.75) | |
III | 14 (43.75) |
Four cases without information.
Five cases without information.
One case without information.